| Literature DB >> 19929706 |
Ciro Costagliola1, Roberto dell'Omo, Mario R Romano, Michele Rinaldi, Lucia Zeppa, Francesco Parmeggiani.
Abstract
The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) reports the characteristics of other antiglaucoma medications: systemic (acetazomide) and topical (dorzolamide and brinzolamide) carbonic anhydrase inhibitors, which suppress aqueous humour formation; and prostaglandin analogues (latanoprost and travoprost) and prostamides (bimatoprost), which raise aqueous humour outflow. The pharmacologic properties of each compound and its efficacy in the medical treatment of glaucoma, mainly the primary open-angle form, are discussed briefly, focusing on the clinical evidence supporting their use.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19929706 DOI: 10.1517/14656560903300129
Source DB: PubMed Journal: Expert Opin Pharmacother ISSN: 1465-6566 Impact factor: 3.889